Home/Filings/4/0001125345-23-000030
4//SEC Filing

Eck Stephen L. 4

Accession 0001125345-23-000030

CIK 0001125345other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:27 PM ET

Size

7.7 KB

Accession

0001125345-23-000030

Insider Transaction Report

Form 4
Period: 2023-02-15
Eck Stephen L.
Chief Medical Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2023-02-15+200,000200,000 total
    Exercise: $4.82Exp: 2033-02-15Common Stock (200,000 underlying)
  • Award

    Restricted Stock Unit

    2023-02-15+50,00050,000 total
    Exercise: $0.00Common Stock (50,000 underlying)
Footnotes (3)
  • [F1]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
  • [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
  • [F3]The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeother

Related Parties

1
  • filerCIK 0001669041

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:27 PM ET
Size
7.7 KB